MIG
LXRX icon

Mariner Investment Group’s Lexicon Pharmaceuticals LXRX Stock Holding History

Mariner Investment Group’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-38,808
Closed -$257K – 228
2015
Q1 		$257K Hold
38,808
– – 0.07% 139
2014
Q4 		$247K Buy
+38,808
New +$313K 0.04% 200

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return

Mariner Investment Group's LXRX Position: Q2 2015 in Review

Mariner Investment Group sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2015, closing a stake of 38,808 shares — an estimated $257K sold.

Mariner Investment Group first reported a position in LXRX in Q4 2014 and held it in 2 quarters. The position peaked at $257K in Q1 2015. 94 funds tracked by Wall St. Rank hold LXRX as of Q2 2015.

  • Mariner Investment Group reported no remaining Lexicon Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Mariner Investment Group sold 38,808 Lexicon Pharmaceuticals shares in Q2 2015, an estimated $257K.
  • Mariner Investment Group first reported a position in Lexicon Pharmaceuticals in Q4 2014 and held it in 2 quarters.
  • Mariner Investment Group's Lexicon Pharmaceuticals position peaked at $257K in Q1 2015.
  • 94 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2015.

Based on Mariner Investment Group's 13F filing for Q2 2015, filed 14 Aug 2015.